End-Stage Renal Disease
End-Stage Renal Disease (ESRD) occurs when chronic kidney disease (CKD) has reached the stage where kidney function is less than 10 percent of its capacity. The primary treatments for End-Stage Renal Disease are dialysis or a kidney transplant. In some cases, lifestyle changes and medications may help.
DelveInsight investigates a robust End-Stage Renal Disease pipeline with more than 20 drugs that are under different phases of development. Even though there is a presence of many therapeutic drugs for the End-Stage Renal Disease treatment scenario, there is still no permanent cure found for this disease.
Acquire a complete picture of the disease, causes, its signs and symptoms, and diagnostics tests through our newsletter. Explore more about End-Stage Renal Disease epidemiological statistics, current ESRD treatment therapies, current, marketed as well as emerging drugs in the End-Stage Renal Disease domain. The newsletter also comprises the End-Stage Renal Disease market landscape, ongoing clinical trials with significant pharmaceuticals involved, novel pipeline therapies, features recent news and happenings, mergers and collaborations, licensing deals, and top conferences anticipated in the End-Stage Renal Disease sphere.
Track fresh updates of End-Stage Renal Disease news and recent developments by subscribing to our mailing list.
Download our Newsletter by simply filling up the form towards the right and stay connected to learn more about fresh occurring in the Chronic Kidney Disease field.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Market insights
- End-Stage Renal Disease Market Dynamics
- Collaborations and deals in the domain